| 2 | Hepatocellular carcinoma (HCC) risk stratification after virological cure for hepatitis C virus (HCV)-induced cirrhosis: time to refine predictive models显示文摘Direct-acting antivirals(DAAs)have revolutionized antiviral treatment for chronic hepatitis C virus(HCV)infection,especially with the interferon-free regimens of the past 5 years.Having a cure for a virus that has been identified(only)30 years ago is unique in medical history.Importantly,even in case of advanced liver disease,cohort studies showed that patients attaining a sustained virological response(SVR)have a 3-to 4-fold reduced risk of hepatocellular carcinoma(HCC)(1-3). | Raoel Maan Adriaan J.van der Meer | 2021 | Hepatobiliary Surgery and Nutrition2021，10，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员